Last reviewed · How we verify
Other Parkinson's Disease treatments — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Other Parkinson's Disease treatments (Other Parkinson's Disease treatments) — Merck Sharp & Dohme LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Other Parkinson's Disease treatments TARGET | Other Parkinson's Disease treatments | Merck Sharp & Dohme LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Other Parkinson's Disease treatments CI watch — RSS
- Other Parkinson's Disease treatments CI watch — Atom
- Other Parkinson's Disease treatments CI watch — JSON
- Other Parkinson's Disease treatments alone — RSS
Cite this brief
Drug Landscape (2026). Other Parkinson's Disease treatments — Competitive Intelligence Brief. https://druglandscape.com/ci/other-parkinson-s-disease-treatments. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab